The DVL1 gene helps cells pass along signals that guide early growth and how body parts form in the right place. In medicine, this gene is important because it helps regulate a major cell communication pathway used during development, especially in bones and other growing tissues. Certain disruptive variants in the DVL1 gene can cause Robinow syndrome, which may involve short stature, differences in the spine or limbs, distinctive facial features, and sometimes developmental delays. Many other variants in this gene have little or no effect.
What is a gene?
Genes are sections of DNA that provide cells with instructions to make molecules or direct processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that carry out much of their work. Other genes are used mainly to regulate when certain processes happen, where they take place, and how strongly they operate. As a group, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
DVL1Gene function
What if the gene works
The DVL1 gene helps cells pass along Wnt signals, which guide growth and where body parts form. This supports early development and helps bone, face, and nervous system tissues develop in an organized way.
Risk
What if the gene does not work
Variants in the DVL1 gene are best known for causing Robinow syndrome, which can affect bone growth, the face, spine, and genitals. Effects vary, and milder or more severe variants may change which features appear and how marked they are.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic variants in the DVL1 gene. The DVL1 gene is being studied within the Wnt signaling pathway in cancer and developmental research, but this has not yet led to routine treatment choices.
Conditions associated with DVL1
Gene function
What if the gene works
Your cells use the DVL1 gene to pass along signals that help the body grow in an organized way. These messages are especially important in early development, when cells need clear instructions about position, timing, and identity. Understanding the DVL1 gene’s function helps explain how tissues take shape and keep their structure.
The DVL1 gene helps pass WNT signals (messages that guide growth and body layout) from the cell surface to the inside of the cell. This lets cells respond to nearby instructions at the right time.
Through these signals, the DVL1 gene helps influence which genes are turned on or off. This supports normal cell growth, cell specialization, and tissue formation.
The DVL1 gene also helps cells line up and move in a coordinated way. This supports organized tissue shaping during early development and normal tissue structure later on.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the DVL1 gene change how the protein is built by altering how the cell reads DNA instructions near the gene's end. This shows how variants in the DVL1 gene affect the protein: it keeps its front section but gains an abnormal tail, which can disrupt cell signaling and protein interactions. Milder changes may have smaller effects, while these more disruptive variants are linked to Robinow syndrome and can influence how marked the features are.
How variants are linked to conditions
Pathogenic variants in the DVL1 gene cause autosomal dominant Robinow syndrome, a condition that affects bone growth and body shape. People with this diagnosis may have short stature, shorter arms or fingers, distinct facial features, and sometimes differences in the teeth, spine, or genitals. Features vary from person to person, even within the same family. In clinical genetics, DVL1 gene variants are most clearly linked to autosomal dominant Robinow syndrome.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DVL1, risk is mainly shaped by whether a disease-causing change in the gene is present and whether it was inherited or happened for the first time in that child. Specific lifestyle or environmental factors are not known to clearly increase or reduce this risk. People with a family history of a DVL1-related condition can get personal risk information from a doctor or genetic counselor.
Inheritance of DVL1 variants
Variants in the DVL1 gene are inherited in an autosomal dominant pattern for DVL1-related Robinow syndrome, which means a child can inherit the condition if just one parent carries the variant. If a parent has the variant, each pregnancy has a 50% chance of passing it on. Some cases happen because of a new, de novo variant, so the change starts in the child and is not inherited from either parent. This is the main answer to how DVL1 gene variants are inherited in families.
What does my DVL1 result mean for my family?
For DVL1, the main family pattern is dominant, which means a parent with the same disease-causing change can pass it on to a child, and close relatives may also carry it. In families with a confirmed DVL1-related condition such as Robinow syndrome, parents, children, brothers, and sisters may sometimes want to learn whether they have the same change. Some cases happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
DVL1 genetic testing looks for variants in a blood sample or cheek swab. A lab reads the DNA code to see whether a variant is present, often as part of a multigene panel or exome sequencing. Results can show a disease causing variant, no relevant variant, or a finding that needs more interpretation.
When should I consider getting a genetic test?
Genetic testing for the DVL1 gene may be worth considering when someone has signs of Robinow syndrome, such as short stature, differences in bone growth, distinctive facial features, or hand and foot differences. It can also help when this condition runs in the family or when a child has these features without a clear cause.
A genetic result is only one part of your health story
Genetic findings can be informative, yet how much they reveal varies by the condition and the specific variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information adds context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, these results may help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines and how strongly you respond to them. Small differences in genes can change how a drug is broken down, moved through the body, or how well it reaches its target. That helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medicine. It looks at connections between genes and medications to help explain why the same treatment can work differently from one person to another. For many drugs, genes can influence how strongly a medicine works or how the body handles it. This information can support more informed, more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the DVL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or general health are best discussed with your doctor or pharmacist.
History
The story behind the DVL1 gene began with work in fruit flies, where researchers identified a gene called dishevelled because altered embryos showed disrupted body patterning. Building on this early work, scientists later found closely related human genes, including the DVL1 gene, as Wnt signaling research expanded in the 1990s. This placed DVL1 within a broader shift in genetics, from describing visible developmental patterns to tracing them to specific genes. Over time, descriptions became more precise as studies linked variants in the DVL1 gene to a form of Robinow syndrome. That connection helped move DVL1 from basic research into clinical genetics. Today, its history reflects how discoveries in model organisms can lead to clearer answers for families affected by inherited conditions.